Reuters logo
BRIEF-IsoRay Inc announces the launch of a Phase II, multicenter clinical trial
November 9, 2017 / 1:16 PM / in a month

BRIEF-IsoRay Inc announces the launch of a Phase II, multicenter clinical trial

Nov 9 (Reuters) - Isoray Inc:

* Announces the launch of a Phase II, multicenter clinical trial with Cesium-131 adjuvant radiation for Retroperitoneal Sarcoma Delivery System (Cards Trial) by University of Louisville, division of surgical oncology Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below